GONZALEZ-RIVAS, J. P., J. I. MECHANICK, M. M. INFANTE-GARCIA, J. R. MEDINA-INOJOSA, Iuliia PAVLOVSKA, O. HLINOMAZ, P. ZAK, Šárka KUNZOVÁ, R. NIETO-MARTINEZ, Mária SKLADANÁ, J. BROZ, J. P. HERNANDEZ, F. LOPEZ-JIMENEZ and G. B. STOKIN. Prevalence of dysglycaemia-based chronic diasease (DBCD) in Brno, Czech Republic: a new paradigm to address diabetes burden. The Kardiovize study. In 56th EASD Annual Meeting 21-25 September 2020. 2020. ISSN 0012-186X. Available from: https://dx.doi.org/10.1007/s00125-020-05221-5.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prevalence of dysglycaemia-based chronic diasease (DBCD) in Brno, Czech Republic: a new paradigm to address diabetes burden. The Kardiovize study
Authors GONZALEZ-RIVAS, J. P., J. I. MECHANICK, M. M. INFANTE-GARCIA, J. R. MEDINA-INOJOSA, Iuliia PAVLOVSKA, O. HLINOMAZ, P. ZAK, Šárka KUNZOVÁ, R. NIETO-MARTINEZ, Mária SKLADANÁ, J. BROZ, J. P. HERNANDEZ, F. LOPEZ-JIMENEZ and G. B. STOKIN.
Edition 56th EASD Annual Meeting 21-25 September 2020, 2020.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30202 Endocrinology and metabolism
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 10.122
Organization unit Faculty of Medicine
ISSN 0012-186X
Doi http://dx.doi.org/10.1007/s00125-020-05221-5
UT WoS 000565776600346
Keywords in English dysglycaemia-based chronic diasease; Kardiovize study
Tags International impact, Reviewed
Changed by Changed by: MUDr. Mária Hrabčaková, učo 358868. Changed: 5/1/2022 10:59.
Abstract
In contrast to the decreasing mortality rates observed with cardiovascular disease (CVD), mortality rates with diabetes increased by 68% in Czechia, in the last decade. The American Association of Clinical Endocrinologists developed a new framework termed Dysglycemia-Based Chronic Disease (DBCD), a multimorbidity care model consisting of 4 distinct stages along the insulin resistance-prediabetes-type 2 diabetes (T2D)-CVD spectrum, prompting a complication-centric, rather than a glucocentric approach. This paper presents the prevalence rates and associated risk factors of each DBCD stage.
PrintDisplayed: 10/10/2024 09:44